- Home
- RNXT vs CMBM Comparison
RNXT vs CMBM Comparison
Compare RNXT & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- CMBM
- Stock Information
- Founded
- RNXT 2012
- CMBM 2011
- Country
- RNXT United States
- CMBM United States
- Employees
- RNXT N/A
- CMBM N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- RNXT Health Care
- CMBM Technology
- Exchange
- RNXT Nasdaq
- CMBM Nasdaq
- Market Cap
- RNXT 44.6M
- CMBM 9.6M
- IPO Year
- RNXT 2021
- CMBM 2019
- Fundamental
- Price
- RNXT $1.37
- CMBM $0.51
- Analyst Decision
- RNXT Strong Buy
- CMBM Strong Buy
- Analyst Count
- RNXT 2
- CMBM 2
- Target Price
- RNXT $7.25
- CMBM $5.50
- AVG Volume (30 Days)
- RNXT 140.4K
- CMBM 461.3K
- Earning Date
- RNXT 08-12-2025
- CMBM 08-07-2025
- Dividend Yield
- RNXT N/A
- CMBM N/A
- EPS Growth
- RNXT N/A
- CMBM N/A
- EPS
- RNXT N/A
- CMBM N/A
- Revenue
- RNXT $240,000.00
- CMBM $172,215,000.00
- Revenue This Year
- RNXT $3,104.65
- CMBM N/A
- Revenue Next Year
- RNXT $301.89
- CMBM $17.73
- P/E Ratio
- RNXT N/A
- CMBM N/A
- Revenue Growth
- RNXT N/A
- CMBM N/A
- 52 Week Low
- RNXT $0.75
- CMBM $0.23
- 52 Week High
- RNXT $1.69
- CMBM $2.50
- Technical
- Relative Strength Index (RSI)
- RNXT 53.41
- CMBM 60.18
- Support Level
- RNXT $1.29
- CMBM $0.39
- Resistance Level
- RNXT $1.38
- CMBM $0.43
- Average True Range (ATR)
- RNXT 0.07
- CMBM 0.04
- MACD
- RNXT -0.01
- CMBM 0.01
- Stochastic Oscillator
- RNXT 48.39
- CMBM 83.31
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.